Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	177.82	35.37	12.73
Graham Fair Price	-49.78	865.82	1723.91
PEG	2419.40	-0.46	0.02
Price/Book	4.88	1.63	1.55
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	331.50	34.76	8.06
Price/Sales	42.18	3.41	2.40
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	3.85	0.56	0.54
Operating Margin	-60.32	0.04	0.11
ROA	-76.37	< 0.005	0.04
ROE	0.05	0.01	-75.69
ROIC	0.05	0.01	-72.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-1.00	0.20	392.31
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.74	-0.70	-81.26
EPS QOQ	4.39	-0.75	-82.87
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.33	-0.25	-24.96
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.72	25.00	69.81
Days Sales Outstanding (DSO)	27.03	27.17	0.53
Inventory Turnover	6.11	3.60	-41.11
Debt/Capitalization	0.00	< 0.005	100.00
Quick Ratio	4.49	3.74	-16.55
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	1654.80	1685.81	1.87
Cash	921.35	1022.35	10.96
Capex	n.A.	n.A.	n.A.
Free Cash Flow	n.A.	n.A.	n.A.
Revenue	1071.06	804.86	-24.85
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	4.83	4.06	-15.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-7.02	-20.95	-198.58
Naive Interpretation	Member

06 - Financial Health · Bad

Rating